Mars Petcare acquires OptiGenApril 12, 2018 Mars Petcare acquired OptiGen LLC, a DNA diagnostics company specializing in canine inherited eye disorders. Included in the acquisition are exclusive licenses to a portfolio of genetic disease tests patented in the U.S., Australia, and many countries in Europe, and an extensive biobank of more than 150,000 samples collected over 20 years representing various canine eye diseases. Moving forward these samples will be used to discover new …
SPONSORED CONTENTHelp save more lives with this parvovirus innovationOur Canine Parvovirus Monoclonal Antibody offered a 93% real-world survival rate for puppies afflicted with parvovirus.1 Discover the future of parvo treatment today! + Read More